Therapeutic Advances in Diabetic Kidney Disease

Although sodium glucose co-transporter type 2 (SGLT-2) inhibitors were initially introduced as glucose-lowering medications, it was later discovered that cardiorenal protection is the most important treatment effect of these agents. A triad of landmark trials consistently showed the benefits of SGLT...

Descripción completa

Detalles Bibliográficos
Autores principales: Georgianos, Panagiotis I., Vaios, Vasilios, Eleftheriadis, Theodoros, Papachristou, Evangelos, Liakopoulos, Vassilios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917247/
https://www.ncbi.nlm.nih.gov/pubmed/36769113
http://dx.doi.org/10.3390/ijms24032803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917247/
https://www.ncbi.nlm.nih.gov/pubmed/36769113
http://dx.doi.org/10.3390/ijms24032803

Ejemplares similares